Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effects of rosiglitazone, a medicine commonly used to treat
type 2 diabetes, on the utilization of glucose by the heart in patients with heart failure
which is not due to heart attacks. The primary purpose of the study is to determine whether
treatment with an insulin-sensitizing medication will improve the heart's ability to
metabolize glucose (sugar).